Richard H. Haas

Quick facts

Marketed products

• Low dose levetiracetam · Neurology
  Low-dose levetiracetam reduces neuronal excitability by binding to synaptic vesicle protein SV2A, modulating neurotransmitter release.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Richard H. Haas portfolio CI brief
• Richard H. Haas pipeline updates RSS